Hi everyone. I'm new to the board but have been ho
Post# of 154003
(Total Views: 448)
Posted On: 03/16/2020 11:02:49 AM
Hi everyone. I'm new to the board but have been holding CYDY since Oct 2018. Never sold a share and continue to accumulate.
I just thought with our little company being in the green today it could bring a lot of new people poking around here looking for answers. So to quote Dr. Patterson on how the science works for Covid-19.
Bruce Patterson M.D., CEO of IncellDX and advisor to CytoDyn explains: “Leronlimab inhibits migration of Tregs, which can inhibit the innate immune response against pathogens, into areas of inflammation. Most importantly, the migration of macrophages and the release of inflammatory cytokines including TNF and IL-6 (cytokine storm) is what causes the profound damage in the lungs in some patients. Leronlimab binding to CCR5 changes the macrophages migration and cytokine production. Taken together, these activities may reduce the morbidity and mortality in moderate to severe cases of COVID-19. IncellDx has developed a suite of diagnostics to monitor these effects of leronlimab on the immune system in these critical patients.”
I just thought with our little company being in the green today it could bring a lot of new people poking around here looking for answers. So to quote Dr. Patterson on how the science works for Covid-19.
Bruce Patterson M.D., CEO of IncellDX and advisor to CytoDyn explains: “Leronlimab inhibits migration of Tregs, which can inhibit the innate immune response against pathogens, into areas of inflammation. Most importantly, the migration of macrophages and the release of inflammatory cytokines including TNF and IL-6 (cytokine storm) is what causes the profound damage in the lungs in some patients. Leronlimab binding to CCR5 changes the macrophages migration and cytokine production. Taken together, these activities may reduce the morbidity and mortality in moderate to severe cases of COVID-19. IncellDx has developed a suite of diagnostics to monitor these effects of leronlimab on the immune system in these critical patients.”
(2)
(0)